ENTA icon

Enanta Pharmaceuticals

107 hedge funds and large institutions have $391M invested in Enanta Pharmaceuticals in 2024 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 25 increasing their positions, 52 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding in top 10

Funds holding in top 10:

more capital invested

Capital invested by funds: $ → $

more call options, than puts

Call options by funds: $ | Put options by funds: $

more first-time investments, than exits

New positions opened: | Existing positions closed:

5.25% more ownership

Funds ownership: 100.66%105.91% (+5.2%)

2% more funds holding

Funds holding: 105107 (+2)

52% less repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 52

Holders
107
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$164K
Puts
$126K
Net Calls
Net Calls Change

Top Sellers

1 -$14.5M
2 -$6.4M
3 -$5.25M
4
Goldman Sachs
Goldman Sachs
New York
-$1.68M
5
BlackRock
BlackRock
New York
-$1.67M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$36.6M
2
$35.7M
3
$33.7M
4
$32.1M
5
$21.6M
6
$19.6M
7
$16.6M
8
$16.3M
9
$15M
10
$14.9M
11
$12.3M
12
$10.2M
13
$10.1M
14
$9.96M
15
$9.19M
16
$9.02M
17
$7.72M
18
$7.4M
19
$6.78M
20
$5.24M
21
$4.92M
22
$4.49M
23
$3.63M
24
$3.4M
25
$3.3M